$CHCO
CITY HOLDING CO

2023 Q4 Form 10-Q Financial Statement

#000072685423000156 Filed on November 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $70.19M
YoY Change 38.15%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.056M $1.200M
YoY Change -18.27% -8.88%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $14.58M
YoY Change 619.75%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $34.09M $37.80M
YoY Change -9.08% 8.62%
Income Tax $6.641M $7.957M
% Of Pretax Income 19.48% 21.05%
Net Earnings $27.20M $29.84M
YoY Change -10.45% 9.0%
Net Earnings / Revenue 42.51%
Basic Earnings Per Share $1.98
Diluted Earnings Per Share $1.84 $1.98
COMMON SHARES
Basic Shares Outstanding 14.83M shares 15.01M shares
Diluted Shares Outstanding 14.95M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $156.3M $110.7M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $72.15M $72.68M
YoY Change 1.92% 1.39%
Goodwill $149.9M
YoY Change 37.65%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $42.22M $58.80M
YoY Change -5.94% 17.86%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $6.168B $6.076B
YoY Change 4.93% 2.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $309.9M $278.7M
YoY Change 6.49% -8.57%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $309.9M $278.7M
YoY Change 6.49% -8.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $121.9M $142.2M
YoY Change -12.59% 3.9%
Total Long-Term Liabilities $121.9M $142.2M
YoY Change -12.59% 3.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $309.9M $278.7M
Total Long-Term Liabilities $121.9M $142.2M
Total Liabilities $5.491B $5.466B
YoY Change 3.6% 1.23%
SHAREHOLDERS EQUITY
Retained Earnings $780.3M $763.4M
YoY Change 10.42% 11.34%
Common Stock $47.62M $224.7M
YoY Change 0.0% 3.2%
Preferred Stock
YoY Change
Treasury Stock (at cost) $217.7M $211.4M
YoY Change 0.83% 0.85%
Treasury Stock Shares
Shareholders Equity $677.1M $610.1M
YoY Change
Total Liabilities & Shareholders Equity $6.168B $6.076B
YoY Change 4.93% 2.16%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $27.20M $29.84M
YoY Change -10.45% 9.0%
Depreciation, Depletion And Amortization $1.056M $1.200M
YoY Change -18.27% -8.88%
Cash From Operating Activities $33.58M $36.70M
YoY Change -1.38% 0.9%
INVESTING ACTIVITIES
Capital Expenditures $562.0K $700.0K
YoY Change 21.12% -211.64%
Acquisitions
YoY Change
Other Investing Activities -$17.56M -$74.20M
YoY Change 25.41% -48.08%
Cash From Investing Activities -$18.12M -$74.90M
YoY Change 25.28% -47.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.22M -82.50M
YoY Change -125.62% -71.69%
NET CHANGE
Cash From Operating Activities 33.58M 36.70M
Cash From Investing Activities -18.12M -74.90M
Cash From Financing Activities 30.22M -82.50M
Net Change In Cash 45.68M -120.7M
YoY Change -146.44% -69.72%
FREE CASH FLOW
Cash From Operating Activities $33.58M $36.70M
Capital Expenditures $562.0K $700.0K
Free Cash Flow $33.02M $36.00M
YoY Change -1.69% -2.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
100000000 usd
CY2023Q3 us-gaap Other Liabilities
OtherLiabilities
142187000 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
139424000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
5465992000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5300254000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
25
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19047548 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19047548 shares
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4146125 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4259399 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
47619000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
47619000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
177113000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
170980000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
763425000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
706696000 usd
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
211430000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
215955000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-163171000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-128066000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
3422000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
3422000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-166593000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-131488000 usd
CY2023Q3 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
910000 usd
CY2022Q3 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
1228000 usd
CY2023Q3 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
1265000 usd
CY2022Q3 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
1530000 usd
CY2023Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
70189000 usd
CY2022Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
50807000 usd
CY2023Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
10551000 usd
CY2022Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1585000 usd
CY2023Q3 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
2990000 usd
CY2022Q3 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
440000 usd
CY2023Q3 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
1034000 usd
CY2022Q3 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
0 usd
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
200000 usd
CY2022Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
730000 usd
CY2023Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
55414000 usd
CY2022Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
48052000 usd
CY2023Q3 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
-730000 usd
CY2022Q3 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0 usd
CY2023Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 usd
CY2022Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
1000 usd
CY2023Q3 us-gaap Noninterest Income Other
NoninterestIncomeOther
742000 usd
CY2022Q3 us-gaap Noninterest Income Other
NoninterestIncomeOther
792000 usd
CY2023Q3 us-gaap Noninterest Income
NoninterestIncome
17410000 usd
CY2022Q3 us-gaap Noninterest Income
NoninterestIncome
18244000 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
18289000 usd
CY2023Q3 us-gaap Occupancy Net
OccupancyNet
2950000 usd
CY2022Q3 us-gaap Occupancy Net
OccupancyNet
2664000 usd
CY2023Q3 us-gaap Equipment Expense
EquipmentExpense
2830000 usd
CY2022Q3 us-gaap Equipment Expense
EquipmentExpense
2949000 usd
CY2023Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
919000 usd
CY2022Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
416000 usd
CY2022Q3 us-gaap Advertising Expense
AdvertisingExpense
854000 usd
CY2023Q3 chco Bankcard Expenses
BankcardExpenses
2188000 usd
CY2022Q3 chco Bankcard Expenses
BankcardExpenses
1405000 usd
CY2023Q3 us-gaap Postage Expense
PostageExpense
668000 usd
CY2022Q3 us-gaap Postage Expense
PostageExpense
578000 usd
CY2023Q3 us-gaap Supplies Expense
SuppliesExpense
457000 usd
CY2022Q3 us-gaap Supplies Expense
SuppliesExpense
466000 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
529000 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
532000 usd
CY2023Q3 us-gaap Communication
Communication
568000 usd
CY2022Q3 us-gaap Communication
Communication
651000 usd
CY2023Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-40000 usd
CY2022Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
3000 usd
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2000 usd
CY2022Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2023Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
4798000 usd
CY2022Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
3591000 usd
CY2023Q3 us-gaap Noninterest Expense
NoninterestExpense
35028000 usd
CY2022Q3 us-gaap Noninterest Expense
NoninterestExpense
31501000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37796000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7957000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7421000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
29839000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14922000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14776000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14906000 shares
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
23000 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
24000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
22000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14928000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.98
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.78
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.98
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.77
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
27374000 usd
us-gaap Net Income Loss
NetIncomeLoss
86913000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-48273000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-81133000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-46132000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-730000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0 usd
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
43000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-47543000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-81133000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-11398000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-19634000 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-11070000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-36145000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-61499000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-35105000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34125000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
51808000 usd
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
720000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
548288000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
636192000 usd
CY2023Q3 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
278671000 usd
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
290964000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
0 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
25
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
610134000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6076126000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5878106000 usd
CY2023Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
55582000 usd
CY2022Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
38493000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
14575000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
2025000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
55614000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
48782000 usd
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
17398000 usd
CY2023Q3 us-gaap Advertising Expense
AdvertisingExpense
790000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
34795000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14878000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
23000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14945000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14901000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.75
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-210741000 usd
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-46175000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-210741000 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-50999000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6306000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-88334000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
591993000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
27374000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-61499000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.65
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
9650000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
754000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
556 shares
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
36000 usd
CY2022Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
8971 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
29839000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
29839000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-36145000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.72
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10662000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
681000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
109382 shares
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9771000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
610134000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
681105000 usd
us-gaap Net Income Loss
NetIncomeLoss
71408000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-159742000 usd
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.85
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
27577000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2412000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
13634 shares
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
697000 usd
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
255421 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
20015000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
548288000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
578027000 usd
us-gaap Net Income Loss
NetIncomeLoss
86913000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-35105000 usd
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
2.02
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
30359000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2407000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
596969 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
53827000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
62078000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
610134000 usd
us-gaap Net Income Loss
NetIncomeLoss
86913000 usd
us-gaap Net Income Loss
NetIncomeLoss
71408000 usd
chco Amortizationand Accretion Net
AmortizationandAccretionNet
6496000 usd
chco Amortizationand Accretion Net
AmortizationandAccretionNet
8607000 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
3543000 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-26000 usd
us-gaap Depreciation
Depreciation
3452000 usd
us-gaap Depreciation
Depreciation
4033000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1491000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1181000 usd
us-gaap Pension Expense
PensionExpense
39000 usd
us-gaap Pension Expense
PensionExpense
192000 usd
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
110000 usd
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-1322000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2407000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2412000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
-203000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
-189000 usd
us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
4819000 usd
us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
3746000 usd
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
9591000 usd
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
29139000 usd
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
9713000 usd
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
29422000 usd
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
122000 usd
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
283000 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
69000 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1629000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-12068000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
11312000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4588000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
9136000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
104044000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
81767000 usd
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
107988000 usd
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
85289000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
56734000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
488401000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
103249000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
93927000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
177875000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
5970000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
280000 usd
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
77000 usd
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
116000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
747000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2392000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1677000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
283000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
189000 usd
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
207000 usd
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
3623000 usd
chco Payments To Acquire Low Income Housing Tax Credits
PaymentsToAcquireLowIncomeHousingTaxCredits
6577000 usd
chco Payments To Acquire Low Income Housing Tax Credits
PaymentsToAcquireLowIncomeHousingTaxCredits
2144000 usd
chco Proceeds From Acquisition Of Business Gross
ProceedsFromAcquisitionOfBusinessGross
14013000 usd
chco Proceeds From Acquisition Of Business Gross
ProceedsFromAcquisitionOfBusinessGross
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
32842000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-395988000 usd
us-gaap Net Change Noninterest Bearing Deposits Domestic
NetChangeNoninterestBearingDepositsDomestic
-78236000 usd
us-gaap Net Change Noninterest Bearing Deposits Domestic
NetChangeNoninterestBearingDepositsDomestic
56156000 usd
us-gaap Net Change Interest Bearing Deposits Domestic
NetChangeInterestBearingDepositsDomestic
-145344000 usd
us-gaap Net Change Interest Bearing Deposits Domestic
NetChangeInterestBearingDepositsDomestic
-23625000 usd
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-18793000 usd
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-7651000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
100000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
53827000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20015000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
697000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
609000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
572000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
29361000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
27047000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-226170000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22057000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-89284000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-336278000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
200000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
634631000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110716000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
298353000 usd
us-gaap Interest Paid Net
InterestPaidNet
32525000 usd
us-gaap Interest Paid Net
InterestPaidNet
5299000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
26162000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
17834000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
41175000 usd
CY2023Q1 chco Non Impaired Loans
NonImpairedLoans
246400000 usd
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
108941000 usd
CY2023Q3 us-gaap Goodwill Gross
GoodwillGross
150116000 usd
CY2022Q4 us-gaap Federal Home Loan Bank Stock And Federal Reserve Bank Stock
FederalHomeLoanBankStockAndFederalReserveBankStock
21400000 usd
CY2023Q3 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
0 usd
CY2023Q3 chco Non Governmental Issues Exceeding10 Shareholders Equity Threshold
NonGovernmentalIssuesExceeding10ShareholdersEquityThreshold
0 usd
CY2022Q4 chco Non Governmental Issues Exceeding10 Shareholders Equity Threshold
NonGovernmentalIssuesExceeding10ShareholdersEquityThreshold
0 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2783000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2686000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
71423000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
66477000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
480331000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
429944000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
1018159000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
859112000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1572696000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1358219000 usd
CY2023Q3 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
17690000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 usd
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
975000 usd
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
730000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0 usd
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
932000 usd
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-730000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
43000 usd
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
CY2023Q3 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
929000 usd
CY2022Q3 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
105000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
679000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
119000 usd
CY2023Q3 us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
929000 usd
CY2022Q3 us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
104000 usd
us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
612000 usd
us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
1441000 usd
CY2023Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 usd
CY2022Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
1000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
67000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-1322000 usd
CY2022Q4 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
228000 usd
CY2022Q4 chco Financing Receivable Nonaccrual With Allowance
FinancingReceivableNonaccrualWithAllowance
4977000 usd
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
187000 usd
us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
0 usd
us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
0 usd
CY2023Q3 chco Financing Receivable Collateral Dependent
FinancingReceivableCollateralDependent
0 usd
CY2022Q4 chco Financing Receivable Collateral Dependent
FinancingReceivableCollateralDependent
0 usd
CY2023Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
4007482000 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3646258000 usd
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23128000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
17108000 usd
CY2023Q3 us-gaap Notes Receivable Net
NotesReceivableNet
3984354000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
3629150000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
17108000 usd
chco Impact Of Adopting Asu202202
ImpactOfAdoptingASU202202
175000 usd
chco Citizens Purchased Credit Deteriorated Loan Reserves
CitizensPurchasedCreditDeterioratedLoanReserves
2811000 usd
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
2374000 usd
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
2215000 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
3543000 usd
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23128000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
18166000 usd
chco Impact Of Adopting Asu202202
ImpactOfAdoptingASU202202
0 usd
chco Citizens Purchased Credit Deteriorated Loan Reserves
CitizensPurchasedCreditDeterioratedLoanReserves
0 usd
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
2757000 usd
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1628000 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-26000 usd
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
17011000 usd
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
22751000 usd
CY2023Q3 chco Impact Of Adopting Asu202202
ImpactOfAdoptingASU202202
0 usd
CY2023Q3 chco Citizens Purchased Credit Deteriorated Loan Reserves
CitizensPurchasedCreditDeterioratedLoanReserves
0 usd
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
888000 usd
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1065000 usd
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
200000 usd
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23128000 usd
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
17015000 usd
CY2022Q3 chco Impact Of Adopting Asu202202
ImpactOfAdoptingASU202202
0 usd
CY2022Q3 chco Citizens Purchased Credit Deteriorated Loan Reserves
CitizensPurchasedCreditDeterioratedLoanReserves
0 usd
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1307000 usd
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
573000 usd
CY2022Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
730000 usd
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
17011000 usd
CY2023Q3 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
1000000 usd
chco Threshold Periodfor Discontinuanceof Interest Accrual
ThresholdPeriodforDiscontinuanceofInterestAccrual
P90D
CY2023Q3 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
0 usd
CY2023Q3 chco Financing Receivable Nonaccrual With Allowance
FinancingReceivableNonaccrualWithAllowance
4986000 usd
CY2023Q3 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
269000 usd
CY2023Q3 us-gaap Financing Receivable Threshold Period Past Due
FinancingReceivableThresholdPeriodPastDue
P30D
CY2023Q3 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
4986000 usd
CY2023Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
4007482000 usd
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
5205000 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3646258000 usd
CY2023Q3 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
92500000 usd
CY2022Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
83000000 usd
CY2023Q3 us-gaap Hedged Asset Fair Value Hedge Last Of Layer Amount
HedgedAssetFairValueHedgeLastOfLayerAmount
308500000 usd
CY2022Q4 us-gaap Hedged Asset Fair Value Hedge Last Of Layer Amount
HedgedAssetFairValueHedgeLastOfLayerAmount
330000000 usd
CY2023Q3 us-gaap Hedged Asset Fair Value Hedge Last Of Layer Cumulative Increase Decrease
HedgedAssetFairValueHedgeLastOfLayerCumulativeIncreaseDecrease
-2000 usd
CY2022Q4 us-gaap Hedged Asset Fair Value Hedge Last Of Layer Cumulative Increase Decrease
HedgedAssetFairValueHedgeLastOfLayerCumulativeIncreaseDecrease
132000 usd
chco Fair Value Hedge Agreement Notional Amount
FairValueHedgeAgreementNotionalAmount
100000000 usd
CY2023Q3 us-gaap Loans Payable
LoansPayable
2593000 usd
CY2023Q3 us-gaap Derivative Assets
DerivativeAssets
2573000 usd
CY2023Q3 chco Interest And Fee Income Other Loans Cumulative Adjustment
InterestAndFeeIncomeOtherLoansCumulativeAdjustment
20000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
29839000 usd
CY2023Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
137000 usd
CY2022Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
90000 usd
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
412000 usd
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
271000 usd
CY2023Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
210000 usd
CY2022Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
221000 usd
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
630000 usd
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
664000 usd
CY2023Q3 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-86000 usd
CY2022Q3 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-195000 usd
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-257000 usd
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-585000 usd
CY2023Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
13000 usd
CY2022Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
64000 usd
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
39000 usd
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
192000 usd
CY2022Q3 chco Combined Federal And State Income Tax Rate
CombinedFederalAndStateIncomeTaxRate
0.24
chco Combined Federal And State Income Tax Rate
CombinedFederalAndStateIncomeTaxRate
0.24
CY2023Q3 chco Combined Federal And State Income Tax Rate
CombinedFederalAndStateIncomeTaxRate
0.24
chco Combined Federal And State Income Tax Rate
CombinedFederalAndStateIncomeTaxRate
0.24
CY2023Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-36700000 usd
CY2023Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-555000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
33000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-36145000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-61499000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-61499000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
27374000 usd
us-gaap Net Income Loss
NetIncomeLoss
86913000 usd
us-gaap Net Income Loss
NetIncomeLoss
71408000 usd
CY2023Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-281000 usd
CY2022Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-255000 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-813000 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-679000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
29558000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
27119000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
86100000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
70729000 usd
CY2023Q3 us-gaap Distributed Earnings
DistributedEarnings
10554000 usd
CY2022Q3 us-gaap Distributed Earnings
DistributedEarnings
9564000 usd
us-gaap Distributed Earnings
DistributedEarnings
29744000 usd
us-gaap Distributed Earnings
DistributedEarnings
27220000 usd
CY2023Q3 us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
19004000 usd
CY2022Q3 us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
17555000 usd
us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
56356000 usd
us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
43509000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
29558000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
27119000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
86100000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
70729000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14922000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14776000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14906000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14878000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
23000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
24000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
22000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
23000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14945000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14928000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14901000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.98
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.75
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.98
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.75
us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
0 usd
CY2023Q3 us-gaap Derivative Credit Risk Valuation Adjustment Derivative Assets
DerivativeCreditRiskValuationAdjustmentDerivativeAssets
0 usd
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
chco-20230930_pre.xml Edgar Link unprocessable
chco-20230930_def.xml Edgar Link unprocessable
0000726854-23-000156-index-headers.html Edgar Link pending
0000726854-23-000156-index.html Edgar Link pending
0000726854-23-000156.txt Edgar Link pending
0000726854-23-000156-xbrl.zip Edgar Link pending
chco-20230930.htm Edgar Link pending
chco-20230930.xsd Edgar Link pending
chco-20230930_g1.jpg Edgar Link pending
exhibit31a09-30x2023.htm Edgar Link pending
exhibit31b09-30x2023.htm Edgar Link pending
exhibit32a09-30x2023.htm Edgar Link pending
exhibit32b09-30x2023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
chco-20230930_lab.xml Edgar Link unprocessable
chco-20230930_cal.xml Edgar Link unprocessable
chco-20230930_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending